help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kacmarek, R. M.
Right arrow Articles by Slutsky, A. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kacmarek, R. M.
Right arrow Articles by Slutsky, A. S.
American Journal of Respiratory and Critical Care Medicine Vol 173. pp. 1415, (2006)
© 2006 American Thoracic Society


Correspondence

Negative Studies Deserve More Attention

From the Authors:

We thank Dr. Gama de Abreu for his letter regarding our recent article (1). He raises important questions regarding the methodology used to ventilate patients during our trial and the potential utility of perfluorocarbon therapy in general for the management of adult acute respiratory distress syndrome (ARDS). When a clinical trial is designed, investigators struggle to ensure that the control group receives an approach to therapy that is considered at the time of study design to be standard or the best possible based on the best available data. At the time our study began (1998), we based our ventilatory strategies on the best available data that addressed lung protection (1). The mortality in all groups was 15% (control arm) to 26%, equivalent to or better than any other study evaluating ventilatory strategy in ARDS. Although we only enrolled patients 65 yr of age or younger, we obtained these low mortality rates even though our oxygenation entry criteria were more rigorous than those in published ARDS trials, except that of Villar and coworkers (2). Specifically, patients had to first demonstrate a PaO2/FIO2 less than 200 mm Hg on an FIO2 of >= 0.5 with >= 5 cm H2O positive end-expiratory pressure (PEEP). They were then placed on >= 13 cm H2O PEEP with an FIO2 >= 0.5. On these settings they had to maintain a PaO2/FIO2 < 300 mm Hg to be randomized. The ARDSnet only required a PaO2/FIO2 < 300 mm Hg regardless of PEEP or FIO2 (3).

In response to Dr. Gama de Abreu's second question, at the time we began our trial there were laboratory data available on partial liquid ventilation (PLV) with high-frequency ventilation (46). These studies compared high-frequency ventilation and conventional ventilation with and without PLV. In two of the studies, PLV was better able to improve gas exchange (both high-frequency and conventional) (5, 6), and in the third, no differences were observed (4). Thus, to our knowledge there were no important negative experimental data on PLV that used alternate ventilatory modes in the control group.

As Dr. Gama de Abreu indicates, we felt strongly that the negative results from our trial needed to be published so that others would not utilize the approach to perfluorocarbon therapy in ARDS that we used. We agree that it is critical for negative trials to be published, since we can learn just as much from a negative trial as we do from a positive trial, even though the results may not be as exciting.

Robert M. Kacmarek

Massachusetts General Hospital, Boston, Massachusetts

Arthur S. Slutsky

University of Toronto, Toronto, Ontario, Canada

FOOTNOTES

Conflict of Interest Statement: R.M.K. received a $65,000 grant from Alliance Pharmaceuticals in 1999 to support studies of partial liquid ventilation in animal models. A.S.S. has been a paid consultant to Maquet in the field of mechanical ventilation ($10,000/yr). He chaired a DSMB for Leo Pharma in relation to a surfactant trial ($10,000/yr), and was on the Alliance advisory board for the trial presented in this publication, but received no financial compensation for this.

REFERENCES

  1. Kacmarek RM, Wiedemann HP, Lavin PT, Wedel MK, Tütüncü AS, Slutsky AS. Partial liquid ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2006;173:882–889.[Abstract/Free Full Text]
  2. Villar J, Kacmarek RM, Pérez-Méndez L, Aguirre-Jaime A. A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med 2006;34:1311–1319.[CrossRef][Medline]
  3. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301–1308.[Abstract/Free Full Text]
  4. Baden HP, Mellema JD, Bratton SL, O'Rourke PP, Jackson JC. High-frequency oscillatory ventilation with partial liquid ventilation in a model of acute respiratory failure. Crit Care Med 1997;25:299–302.[CrossRef][Medline]
  5. Smith KM, Bing DR, Meyers PA, Connett JE, Boros SJ, Mammel MC. Partial liquid ventilation: a comparison using conventional and high-frequency techniques in an animal model of acute respiratory failure. Crit Care Med 1997;25:1179–1186.[CrossRef][Medline]
  6. Smith KM, Mrozek JD, Simonton SC, Bing DR, Meyers PA, Connett JE, Mammel MC. Prolonged partial liquid ventilation using conventional and high-frequency ventilatory techniques: gas exchange and lung pathology in an animal model of respiratory distress syndrome. Crit Care Med 1997;25:1888–1897.[CrossRef][Medline]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kacmarek, R. M.
Right arrow Articles by Slutsky, A. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kacmarek, R. M.
Right arrow Articles by Slutsky, A. S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2006 American Thoracic Society